Alkaloid extracts of eight Narcissus (Amaryllidaceae) species and varieties were studied with respect to their acetylcholinesterase (HuAChE) and butyrylcholinesterase (HuBuChE) inhibitory activity and alkaloid patterns. Thirty alkaloids were determined by GC/MS, and twenty-five of them identified from their mass spectra, retention times and retention indexes. Promising HuAChE inhibition activity was demonstrated by six Narcissus taxa and HuBuChE inhibition by N. jonquila cv. Double Campernelle and N. nanus cv. Elka with IC 50 values of 24.1 ± 1.9 μg/mL and 25.1 ± 1.8 μg/mL, respectively. Two alkaloids were isolated in pure form using preparative TLC and identified as the galanthamine type alkaloid narwedine and the lycorine type alkaloid incartine. Both compounds were tested for their biological activity. They were considered inactive in HuAChE/HuBuChE assays, but showed promising prolyl oligopeptidase inhibition activities with IC 50 values of 0.95 ± 0.12 mM and 0.91 ± 0.09 mM, respectively.
Plants of the Amaryllidaceae family are known to contain a specific type of compounds, namely the Amaryllidaceae alkaloids, which are of great interest thanks to their wide range of biological properties, including antiviral, antimalarial, anticancer and anticholinesterase activities [1a-1d] . Within this group, the genus Narcissus has been extensively used in traditional medicine to treat a variety of health problems. Since the isolation of lycorine from N. pseudonarcissus in 1877, over 500 alkaloids have been isolated from plants of this family. Among these alkaloids, the most important is galanthamine that is approved for the pharmacological treatment of Alzheimer´s disease under the commercial names of Razadine ® in the USA, and Reminyl ® in Europe and other countries [2] . The search for more potent and effective AChE inhibitors from natural sources has led to the isolation of other Amaryllidaceae alkaloids, such as sanguinine, habranthine and 1-O-acetyllycorine, which possess either similar or stronger activity than galanthamine [3] .
AD is the most predominant cause of dementia in the elderly, affecting more than 20 million people worldwide [4a] . The etiology of AD is still unknown, but postmortem studies have shown two characteristic pathologic hallmarks, senile plaques (SPs) and neurofibrillary tangles (NFTs). SPs are an extracellular accumulation of beta-amyloid (Aß) surrounded by dystrophic neurites and microglia. Aß originates from the proteolysis of the amyloid precursor protein (APP) through sequential cleavage by beta-site amyloid precursor protein-cleaving enzyme 1(BACE-1, ßsecretase) and γ-secretase [4b]. In AD patients, deficit of the neurotransmitter acetylcholine (ACh) in the cortex results in a deterioration of the level of cholinergic functions, and this is responsible for the memory impairments [4c]. The principal role of acetylcholinesterase (AChE) is the termination of nerve impulse transmission at the cholinergic synapses by rapid hydrolysis of acetylcholine. However, not only AChE participates in the cholinergic regulation of the central nervous system (CNS) in humans, but also another enzyme, butyrylcholinesterase (BuChE), which is able to hydrolyze ACh, as well as other esters. BuChE is associated with the NFTs and SPs and its activity increases in the AD brain, where it co-localizes with Aß fibrils [4d]. In severe AD, levels of AChE and choline acetyltransferase are decreased by as much as 90% compared with the normal stage, while the concentration of BuChE increases [4e]. This fact has targeted BuChE as a new approach to affect the progression of AD. Therefore, research into new inhibitors with dual enzymatic activity is required.
Prolyl oligopeptidase (POP) is a cytosolic serine peptidase that hydrolyzes small proline-containing peptides at the carboxy terminus of proline-residues such as vasopressine, substance P, and thyrotropin-releasing hormones that are involved in the process of learning and memory [5a, 5b] . These neuropeptides are known to be important modulators in cognitive functions, and degradation of these peptides by POP may accelerate the aging process and possibly be involved in age-related neurodegenerative diseases [5c]. In recent years, POP has gained importance as a target for the treatment of schizophrenia (SZ), bipolar affective disorder (BD) and cognitive disturbances, such as those present in AD, mainly due to its involvement in the metabolism of inositol-1,4,5-P 3 (IP 3 ), which is a key molecule in the transduction cascade of neuropeptide signaling. Some inhibitors of POP have been found to be potent antidementia drugs [5d, 5e], and, therefore, the inhibition of POP could be an important supporting tool in the treatment of AD.
The genus Narcissus comprises around one hundred wild species, and is mainly distributed in south-western Europe and North Africa, with some populations in the Balkans, Italy and France. Most of the species can hybridize, although fertility depends upon the parental relationship. In fact, hybridization has become very popular and a large numbers of cultivars have been developed for ornamental purposes, with over 27,000 names of Narcissus cultivars now registered in the International Daffodil Register [6a] . Plants of this genus have been used throughout history in traditional medicine to treat a variety of medicinal problems [6b] . N. poeticus is described in the Bible as a well-established treatment for symptoms that would now be defined as cancer [6c]. The influence of the daffodils on the nervous system has led to the use of its flowers and bulbs for hysterical affections and even epilepsy. A homeopathic medicine is also made from the bulbs and used for respiratory disease, particularly bronchitis and whooping cough [6d].
Only a few studies have been published on the galanthamine content of ornamental Amaryllidaceous plants. The Narcissus cultivars have some advantages for alkaloid production with respect to wild sources of Amaryllidaceae alkaloids in which their production is influenced by growth conditions and the chemical composition of the soil [7] . Phytochemical studies made on Narcissus cultivars showed that the content of galanthamine was unaffected by planting depth and density, bulb size or flower bud removal [8] , but it was positively influenced by standard fertilization levels of nitrogen and potassium in the cultivar 'Carlton' [9] . Another advantage is that ornamental Narcissus cultivars are commercially available in sufficient quantities and thus they can be used for isolation of biological active Amaryllidaceae alkaloids, for example, for medicinal purposes.
In the present work, four ornamental varieties of Narcissus nanus, two ornamental varieties of N. jonquila and two botanical species of Narcissus have been evaluated for their alkaloid profile by GC/MS, as well as their acetylcholinesterase and butyrylcholinestase inhibitory activity. Two alkaloids, incartine (25) and narwedine (8), isolated by preparative TLC from N. jonquilla var. henriquesii and N. poeticus cv. Brackenhurst, respectively, were tested also for their prolyl oligopeptidase inhibition activity.
In the bulb extracts of the studied species, thirty compounds with typical mass spectra of Amaryllidaceae alkaloids were detected. Twenty-seven of them were identified based on their mass spectra, retention times and retention indexes and belong to the crinine (18), galanthamine (1, 2, 5, 7, 8, 11), homolycorine (4, 13, 21, 28), lycorine (9, 10, 12, 14, 15, 16, 17, 20, 22, 24, 25, 29), and tazettine (19, 27) structural type of Amaryllidaceae alkaloids. The relative proportion of each alkaloid was determined as a percentage of the total ion current (TIC). The peak areas reflect the ability of each compound to be ionized and thus the data given in Table 1 are semiquantitative. Nevertheless, they can be used for comparison between samples.
In some Narcissus extracts we detected homolycorine-type alkaloids for which identification by GC/MS with only EI ionization is complicated. This structural type of Amaryllidaceae alkaloids shows weak molecular ions (lower than 1% of TIC). Therefore, we used GC/MS with chemical ionization for the determination of the molecular ions of these alkaloids (4, 13, 28) . Compound 20, tentatively identified as 11,12-didehydroassoanine, showed the mass spectral fragmentation characteristic of lycorine type alkaloids. Its mass spectrum was very similar to that of assoanine. The molecular ion and main fragments were smaller by two units, which indicated an additional double bond in position C-11,12. Both alkaloids showed the same fragmentation pattern as the other lycorine-derivatives anhydrolycorine and 11,12didehydroanhydrolycorine (9, 17) . The complete identification of 20 can only be made after its isolation. Unfortunately, taking into account its low concentration (< 3% of TIC), its isolation might be problematic.
The GC/MS results also showed the presence of compounds with unknown EI fragmentation patterns (3, 6, 23, 30) , the isolation of which could lead to the identification of new Amaryllidaceae alkaloids.
The HuAChE and HuBuChE inhibitory activities of the studied species and varieties were determined by the method employed by Ellman [10] . The results (IC 50 ) are summarized in Table 2 . It is reported that, among the plants of the family Amaryllidaceae, AChE inhibitory activity is associated mainly with galanthamine and lycorine type alkaloids [3, 11] . Alkaloids such as galanthamine, sanguinine, 1-O-acetyllycorine, and assosanine possess remarkable AChE inhibitoty activity [1c, 3, 12] . This fact correlates with our HuAChE inhibitory activity results (Tables 1 and 2 ). In two taxa, N. nanus cv. Little Gem and N. nanus cv. Midget, we found only trace amounts of galanthamine and a low amount of assoanine (< 1% of TIC), which are known AChE inhibitors; these extracts were considered inactive (IC 50 > 100 µg/mL). Other tested Narcissus extracts showed important AChE inhibitory activity, which could be explained by the presence of galanthamine and assoanine in these extracts.
The principal role of AChE is the termination of nerve impulse transmission at the cholinergic synapses by rapid hydrolysis of ACh. However, not only AChE participates in the cholinergic regulation of the CNS in humans, but also another enzyme, BuChE, which is able to hydrolyze ACh, as well as other esters [13] . In severe AD, levels of AChE and choline acetyltransferase are decreased by as much as 90% compared with the normal stage, while the concentration of BuChE increases [4e]. This fact has targeted BuChE as a new approach to affect the progression of AD. However, there is very little information about the BuChE inhibition activity of the Amaryllidaceae alkaloids, with the exception of twenty alkaloids isolated and tested in our laboratory from Zephyranthes robusta, Chlidanthus fragrans, and Narcissus cv. Sir W. Churchill [1c, 14a-14c]. In these assays only galanthamine showed moderate HuBuChE inhibition activity with an IC 50 value 42.3 ± 1.3 µM. Therefore, it is impossible to draw conclusions as yet on the influence of particular functionalities on the BuChE inhibition activity of Amaryllidaceae alkaloids. A wider range of these compounds must be isolated and tested first. In the current study, the best HuBuChE inhibition activity was demonstrated by N. jonquilla cv. Double Campernelle and N. nanus cv. Elka with IC 50 values of 24.1 ± 1.9 μg/mL and 25.1 ± 1.8 μg/mL ( Table 2 ).
The compounds isolated from Narcissus species using prep. TLC were assayed for their inhibitory activity against HuAChE, HuBuChE and also POP ( Table 2 ). Both tested alkaloids unfortunately showed only weak HuAChE and HuBuChE inhibition activities, but they showed important POP inhibition activity with IC 50 values of 0.95 ± 0.12 mM for narwedine and 0.91 ± 0.09 mM for incartine. These obtained activities are comparable with that of baicaline (IC 50 = 0.610 ± 0.021 mM), which has been used as standard. Recent studies have demonstrated that baicalin has a protective effect against brain edema and cerebral ischemic damage [15a, 15b] . Some inhibitors of POP have been found to be potent antidementia drugs, and, therefore, the inhibition of POP could be Alkaloids identified by GC/MS in bulbs of various Narcissus species Natural Product Communications Vol. 9 (8) 2014 1153 an important supporting tool in the treatment of AD. In our previous study, eight Amaryllidaceae alkaloids isolated from Chlidanthus fragrans were tested, but only one compound, identified as the crinine type alkaloid undulatine, showed important POP inhibition activity (IC 50 = 1.96 ± 1.2 mM) [28].
In conclusion, the screening of crude and/or alkaloid extracts from plants, followed by GC/MS analysis, is a good way for searching for new bioactive natural compounds with either AChE/BuChE inhibition or other biological activities. In the case of identification of unknown structures by GC/MS, the isolation of these compounds would be interesting due to their potential activity as cholinesterase inhibitors, antitumor agents and others. The ornamental Narcissus taxa are important sources of Amaryllidaceae alkaloids of various structural types. As shown in our study, the content of pharmaceutically important alkaloids such as galanthamine (treatment of AD) and lycorine, which is suggested as a good candidate therapeutic agent against leukemia [16] , can vary remarkably between the different varieties ( Table 1) . Some of them could be proposed as a source of biological important substances for the pharmaceutical industry. 1154 Natural Product Communications Vol. 9 (8) 2014
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